Dr Reddy's Laboratories terminates Armis Biopharma's investigation license

DFA-02 has been studied in several phase 1 and 2 clinical studies

from Latest News https://ift.tt/2IulFwa
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share